Copyright
©The Author(s) 2020.
World J Diabetes. Dec 15, 2020; 11(12): 572-583
Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.572
Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.572
Figure 2 Effects of formulated SX-fraction and anti-diabetic drug (glipizide) on diabetic parameters in mice.
The two diabetic parameters, glucose and insulin, in the control, SX-fraction, and glipizide groups were analyzed at indicated periods in a one-week trial. The results of glucose and insulin in the three groups are shown in the panels (A) and (B), respectively. All data are mean of 5 mice from each group (aP < 0.05 vs control). SXF: SX-fraction; Glc: Glucose; Ins: Insulin; Glp: Glipizide.
- Citation: Konno S. SX-fraction: Promise for novel treatment of type 2 diabetes. World J Diabetes 2020; 11(12): 572-583
- URL: https://www.wjgnet.com/1948-9358/full/v11/i12/572.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i12.572